Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Vaccine Doubts Weighs On Europe, UK Inflation Almost Halves Month-on-Month

Published 20/05/2020, 09:29
UK100
-
FCHI
-
DJI
-
DE40
-

Unwilling to learn from past mistakes, the markets got overly excited about Morderna’s covid-19 vaccine, only for the Dow Jones’s optimism to be somewhat punctured on Tuesday night.

A report from Boston Globe Media’s STAT news cast doubt on the success of Morderna’s vaccine trials, not because they necessarily were a failure, but because the company failed to provide the ‘critical information’ to allow the rest of the scientific community to assess the vaccine’s efficacy.

This tamping down of expectations caused the Dow to drop close to 400 points on Tuesday, just less than half of the 1000-point growth seen on Monday.

The Dow’s decline fed into the European session, contributing to the smattering of losses seen after the bell. The FTSE slipped under 6000 following a 0.4% decline, while the DAX and CAC were down 0.6% and 0.7% respectively.

The FTSE likely would’ve been lower if it weren’t for sterling falling 0.4% against dollar and euro alike. This as the UK’s inflation fell from 1.5% in March to just 0.8% in April, the lowest figure since August 2016. Energy prices were one of the most significant drags, with food prices also falling slightly; fast food and toys, on the other hand, saw prices increase as customers look for at-home distractions.

Looking ahead to this afternoon and Europe might be able to shake off the morning’s losses if the Dow Jones comes good on its forecast 175 point increase, one that would lift the index back towards 24400.

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.